Health Condition 1: O- Medical and Surgical Health Condition 2: M958- Other specified acquired deformities of musculoskeletal system
Conditions
Interventions
Intervention1: Remifentanyl: Remifentanyl is an ultra-short acting opioid that facilitates hemodynamic and neurologic management. Owing to its short half life it is preferred as an infusion. Postopera
Sponsors
JNMC
Eligibility
Inclusion criteria
Inclusion criteria: Patient giving informed consent No history of substance abuse BMI more than thirty-five ASA grade one, two, three Patients posted for spine surgery
Exclusion criteria
Exclusion criteria: Patients not willing to participate in the study BMI more than thirty-five ASA grade four and above Patients who received opioids within two days prior to surgery Known hypersensitivity to opioids Pregnant females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Remifentanyl is better alternative to Fentanyl in pain management in spine surgery patientsTimepoint: 24 hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Comparison of hemodynamic parameters during intraoperative & postoperative period 2. Assessment of postoperative opioid consumption 3. evaluation of postoperative nausea & vomiting 4. compare total amount of rescue analgesics (IV Tramadol) used during 24 hour postoperative period 5. study side effects & complications during postoperative periodTimepoint: 24 hrs | — |
Countries
India
Contacts
Public ContactNeeta Chaudhary Verma
Datta Meghe Institute of Medical Science and research
Outcome results
None listed